aminoimidazole carboxamide has been researched along with Cardiac Failure in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, A; Furihata, T; Handa, H; Kakutani, N; Kinugawa, S; Maekawa, S; Matsumoto, J; Mizushima, W; Nakano, I; Nambu, H; Sabe, H; Takada, S; Tanaka, S; Yokota, T | 1 |
| Du, B; Gao, L; Huang, Z; Kong, L; Li, Y; Liang, C; Liu, Y; Shi, H; Tian, X; Wang, Z; Wu, L; Yao, R; Zhang, D; Zhang, Y | 1 |
| Gupta, RC; Kohli, S; Lanfear, DE; Rastogi, S; Sabbah, HN; Wang, M; Zhang, K | 1 |
| Ambrosio, G; Clare, RM; Ferguson, TB; Fremes, S; Harrington, RA; Lira, A; Menasché, P; Mongero, L; Newman, MF; Nussmeier, N; Pearl, RG; Pieper, KS; Pitt, B; Reece, TL; Wechsler, AS; Weisel, RD; Yau, TM | 1 |
| Dyck, JR; Kim, TT | 1 |
| Sun, A; Wang, P; Xu, L | 1 |
| Asakura, M; Asanuma, H; Fujita, M; Ito, S; Kim, J; Kitakaze, M; Komamura, K; Minamino, T; Mochizuki, N; Ogai, A; Sanada, S; Sasaki, H; Sugimachi, M; Takahama, H; Takashima, S; Wakeno, M | 1 |
| McGaffin, KR; McTiernan, CF; O'Doherty, RM; O'Donnell, CP; Romano, LC; Witham, WG; Yester, KA | 1 |
| Li, L; Tao, HL; Wang, XF; Zhang, JY; Zhang, L; Zhao, XY | 1 |
2 review(s) available for aminoimidazole carboxamide and Cardiac Failure
| Article | Year |
|---|---|
Is AMPK the savior of the failing heart?
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Energy Metabolism; Heart; Heart Failure; Humans; Metformin; Myocardium; Ribonucleotides | 2015 |
Energy Remodeling, Mitochondrial Disorder and Heart Failure.
Topics: Aminoimidazole Carboxamide; Animals; Energy Metabolism; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondrial Diseases; Ribonucleotides; Thiazolidinediones; Trimetazidine | 2016 |
1 trial(s) available for aminoimidazole carboxamide and Cardiac Failure
| Article | Year |
|---|---|
Predictors of contemporary coronary artery bypass grafting outcomes.
Topics: Age Factors; Aminoimidazole Carboxamide; Aspirin; Cardiopulmonary Bypass; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Bypass; Double-Blind Method; Heart Failure; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; Patient Selection; Peripheral Arterial Disease; Protective Factors; Ribonucleosides; Risk Assessment; Risk Factors; Stroke; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
6 other study(ies) available for aminoimidazole carboxamide and Cardiac Failure
| Article | Year |
|---|---|
Brain-Derived Neurotrophic Factor Improves Impaired Fatty Acid Oxidation Via the Activation of Adenosine Monophosphate-Activated Protein Kinase-ɑ - Proliferator-Activated Receptor-r Coactivator-1ɑ Signaling in Skeletal Muscle of Mice With Heart Failure.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain-Derived Neurotrophic Factor; Exercise Tolerance; Fatty Acids; Heart Failure; Humans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Mitochondria; Muscle, Skeletal; Myocardial Infarction; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Recombinant Proteins; Ribonucleosides | 2021 |
Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Fructose-Bisphosphate Aldolase; Heart; Heart Failure; Male; Mice; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; Up-Regulation | 2018 |
Acute intravenous infusion of an adenosine regulating agent improves left ventricular function in dogs with advanced heart failure.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Deoxyribonucleosides; Dogs; Heart Failure; Hemodynamics; Infusions, Intravenous; Purinergic P1 Receptor Antagonists; Theophylline; Ventricular Function, Left | 2013 |
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Disease Progression; Dogs; Drug Evaluation, Preclinical; Fibrosis; Gene Expression Regulation; Heart Failure; Insulin Resistance; Metformin; Myocytes, Cardiac; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Ribonucleotides; Transforming Growth Factor beta1; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Enzyme Activation; Glycolysis; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Cardiovascular; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Ribonucleotides; Signal Transduction; STAT3 Transcription Factor; Tamoxifen | 2011 |
Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Echocardiography; Heart Failure; Hypoglycemic Agents; Insulin; Male; Metformin; Myocardium; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Ribonucleotides; Ventricular Function, Left; Ventricular Remodeling | 2011 |